Depressive SymptomsAnxiety SymptomsGriefPsychological TraumaInsomniaResilienceStressPsychological Well BeingMarital RelationshipWellbeingCommon Mental Health ProblemsRumination
Investigational drug(s) / intervention(s)
Culturally adapted i-CBT
Culturally adapted i-CBT: A culturally and language adapted i-CBT intervention for Farsi/Dari speaking youth migrants and refugees. The intervention targets mild to moderate common mental health problems.
Study summary
The aim of this randomized controlled trial (RCT) is to investigate the effectiveness of a culturally adapted internet-based cognitive behavioral therapy (i-CBT) intervention in reducing symptoms of common mental health issues among Farsi/Dari-speaking youth migrants and refugees. Investigator hypothesizes that there will be a significant decrease in psychological symptoms after participants receive the intervention compared to a control group.
Eligibility
Sex
ALL
Min age
15 Years
Max age
29 Years
Healthy volunteers
No
Inclusion Criteria:
* Between the ages of 15 and 29.
* A score above the cut-off 1.75 on HSCL-25
* Has a refugee or migrant background
* Has a good and stable internet connection
* Has access to a computer, tablet or smartphone
* Is fluent in reading and writing Arabic
* Has the ability to dedicate time to take part in the intervention for 6-10 weeks.
Exclusion Criteria:
* Is suffering from a severe mental illness, such as psychosis or severe depression.
* Is suffering from substance abuse
* Is undergoing a psychological treatment
* Has a high risk of suicide
Primary outcome measure(s)
Hopkins Symptom Checklist-25 (HSCL-25) — Pre-intervention, up to 5 weeks, immediately after the intervention, 6 months after completion of the intervention Assessment of anxiety and depressive symptoms. HSCL-25 consists of 25 items.Each item is rated on a scale from 1 to 4, where 1 means "Not at all" and 4 means "Extremely".Higher scores indicate a worse outcome, as they reflect greater severity of symptoms.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
